BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 8509711)

  • 21. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway.
    Sehayek E; Eisenberg S
    J Biol Chem; 1991 Sep; 266(27):18259-67. PubMed ID: 1917954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein.
    Weisgraber KH; Mahley RW; Kowal RC; Herz J; Goldstein JL; Brown MS
    J Biol Chem; 1990 Dec; 265(36):22453-9. PubMed ID: 2266137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.
    Huang Y; Liu XQ; Rall SC; Mahley RW
    J Biol Chem; 1998 Jul; 273(28):17483-90. PubMed ID: 9651338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accumulation of an apoE-poor subfraction of very low density lipoprotein in hypertriglyceridemic men.
    Evans AJ; Huff MW; Wolfe BM
    J Lipid Res; 1989 Nov; 30(11):1691-701. PubMed ID: 2614271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced lipolysis of large apo E-poor very-low-density lipoprotein subfractions from type IV hypertriglyceridemic subjects in vitro and in vivo.
    Evans AJ; Wolfe BM; Strong WL; Huff MW
    Metabolism; 1993 Jan; 42(1):105-15. PubMed ID: 8446037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.
    Ji ZS; Fazio S; Mahley RW
    J Biol Chem; 1994 May; 269(18):13421-8. PubMed ID: 8175773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation.
    Whitman SC; Miller DB; Wolfe BM; Hegele RA; Huff MW
    Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1707-15. PubMed ID: 9327767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triglyceride-rich lipoproteins of subjects heterozygous for apolipoprotein E2(Lys146-->Gln) are inefficiently converted to cholesterol-rich lipoproteins.
    Mulder M; van der Boom H; de Knijff P; Braam C; van den Maagdenberg A; Leuven JA; Havekes LM
    Atherosclerosis; 1994 Aug; 108(2):183-92. PubMed ID: 7980718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL.
    Murdoch SJ; Breckenridge WC
    Biochim Biophys Acta; 1996 Oct; 1303(3):222-32. PubMed ID: 8908157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholesteryl ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hypercholesterolemic canine beta-very low density lipoproteins.
    Goldstein JL; Ho YK; Brown MS; Innerarity TL; Mahley RW
    J Biol Chem; 1980 Mar; 255(5):1839-48. PubMed ID: 7354064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is hypertriglyceridemic very low density lipoprotein a precursor of normal low density lipoprotein?
    Oschry Y; Olivecrona T; Deckelbaum RJ; Eisenberg S
    J Lipid Res; 1985 Feb; 26(2):158-67. PubMed ID: 3989374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Murine macrophages secrete factors that enhance uptake of non-lipoprotein [3H]cholesteryl ester by aortic smooth muscle cells.
    Stein O; Ben-Naim M; Dabach Y; Hollander G; Stein Y
    Biochim Biophys Acta; 1994 Jun; 1212(3):305-10. PubMed ID: 8199201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans.
    Huff MW; Miller DB; Wolfe BM; Connelly PW; Sawyez CG
    J Lipid Res; 1997 Jul; 38(7):1318-33. PubMed ID: 9254059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fate of apolipoproteins C-1, C-iii, and E during lipolysis of human very low density lipoproteins in vitro.
    Tam SP; Dory L; Rubinstein D
    J Lipid Res; 1981 May; 22(4):641-51. PubMed ID: 7276737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance of a very low density lipoprotein subpopulation from familial dysbetalipoproteinemia to in vitro lipolytic conversion to the low density lipoprotein density fraction.
    Chung BH; Segrest JP
    J Lipid Res; 1983 Sep; 24(9):1148-59. PubMed ID: 6631244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein lipase enhances the cholesteryl ester transfer protein-mediated transfer of cholesteryl esters from high density lipoproteins to very low density lipoproteins.
    Tall AR; Sammett D; Vita GM; Deckelbaum R; Olivecrona T
    J Biol Chem; 1984 Aug; 259(15):9587-94. PubMed ID: 6746661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Very-low-density lipoprotein-induced triglyceride accumulation in human mesangial cells is mainly mediated by lipoprotein lipase.
    Li J; Li H; Wen YB; Li XW
    Nephron Physiol; 2008; 110(1):p1-10. PubMed ID: 18698144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; LasunciĆ³n MA
    Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.
    Goldberg IJ; Scheraldi CA; Yacoub LK; Saxena U; Bisgaier CL
    J Biol Chem; 1990 Mar; 265(8):4266-72. PubMed ID: 2307668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice.
    Jong MC; Rensen PC; Dahlmans VE; van der Boom H; van Berkel TJ; Havekes LM
    J Lipid Res; 2001 Oct; 42(10):1578-85. PubMed ID: 11590213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.